Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathy
Alzheimers Res Ther. 2021 Nov 16;13(1):189.
doi: 10.1186/s13195-021-00929-x.
1 Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands.
2 Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
3 Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
4 Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
5 Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
6 ADx NeuroSciences, Ghent, Belgium.
7 Department of Geriatrics, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, Nijmegen, The Netherlands.
8 Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands. [email protected].
9 Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. [email protected].